Spikevax receives full TGA registration

Moderna COVID-19 vaccine. Source: Flickr/Governor Tom Wolf under Creative Commons licence.
Moderna’s Spikevax (elasomeran) has become the first Covid-19 vaccine to receive full registration in Australia  Moderna’s application to transition Spikevax from provisional to full registration was approved by the Therapeutic Goods Administration (TGA) on 21 April.   The regulator said the decision to grant the vaccine full registration was made after a review of long-term

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Double dispensing not a ‘done deal’ says petition author
Next Your Say: how readers reacted to double dispensing